312 related articles for article (PubMed ID: 26695882)
1. Sex- and tissue-specific changes in mTOR signaling with age in C57BL/6J mice.
Baar EL; Carbajal KA; Ong IM; Lamming DW
Aging Cell; 2016 Feb; 15(1):155-66. PubMed ID: 26695882
[TBL] [Abstract][Full Text] [Related]
2. Sex-specific mTOR signaling determines sexual dimorphism in myocardial adaptation in normotensive DOCA-salt model.
Gürgen D; Kusch A; Klewitz R; Hoff U; Catar R; Hegner B; Kintscher U; Luft FC; Dragun D
Hypertension; 2013 Mar; 61(3):730-6. PubMed ID: 23339165
[TBL] [Abstract][Full Text] [Related]
3. Regulation of mTOR activity in Snell dwarf and GH receptor gene-disrupted mice.
Dominick G; Berryman DE; List EO; Kopchick JJ; Li X; Miller RA; Garcia GG
Endocrinology; 2015 Feb; 156(2):565-75. PubMed ID: 25456069
[TBL] [Abstract][Full Text] [Related]
4. 17ß-Estradiol regulates mTORC2 sensitivity to rapamycin in adaptive cardiac remodeling.
Kusch A; Schmidt M; Gürgen D; Postpieszala D; Catar R; Hegner B; Davidson MM; Mahmoodzadeh S; Dragun D
PLoS One; 2015; 10(4):e0123385. PubMed ID: 25880554
[TBL] [Abstract][Full Text] [Related]
5. Beneficial metabolic effects of rapamycin are associated with enhanced regulatory cells in diet-induced obese mice.
Makki K; Taront S; Molendi-Coste O; Bouchaert E; Neve B; Eury E; Lobbens S; Labalette M; Duez H; Staels B; Dombrowicz D; Froguel P; Wolowczuk I
PLoS One; 2014; 9(4):e92684. PubMed ID: 24710396
[TBL] [Abstract][Full Text] [Related]
6. Chronic rapamycin treatment exacerbates metabolism and does not down-regulate mTORC2/Akt signaling in diabetic mice induced by high-fat diet and streptozotocin.
Wang Y; He Z; Li X; Chen W; Lu J; Chen X; Cao L
Pharmazie; 2015 Sep; 70(9):604-9. PubMed ID: 26492646
[TBL] [Abstract][Full Text] [Related]
7. Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: a tale of two complexes.
Jhanwar-Uniyal M; Gillick JL; Neil J; Tobias M; Thwing ZE; Murali R
Adv Biol Regul; 2015 Jan; 57():64-74. PubMed ID: 25442674
[TBL] [Abstract][Full Text] [Related]
8. mTOR inhibition suppresses established epilepsy in a mouse model of cortical dysplasia.
Nguyen LH; Brewster AL; Clark ME; Regnier-Golanov A; Sunnen CN; Patil VV; D'Arcangelo G; Anderson AE
Epilepsia; 2015 Apr; 56(4):636-46. PubMed ID: 25752454
[TBL] [Abstract][Full Text] [Related]
9. Next Generation Strategies for Geroprotection via mTORC1 Inhibition.
Dumas SN; Lamming DW
J Gerontol A Biol Sci Med Sci; 2020 Jan; 75(1):14-23. PubMed ID: 30794726
[TBL] [Abstract][Full Text] [Related]
10. Subacute calorie restriction and rapamycin discordantly alter mouse liver proteome homeostasis and reverse aging effects.
Karunadharma PP; Basisty N; Dai DF; Chiao YA; Quarles EK; Hsieh EJ; Crispin D; Bielas JH; Ericson NG; Beyer RP; MacKay VL; MacCoss MJ; Rabinovitch PS
Aging Cell; 2015 Aug; 14(4):547-57. PubMed ID: 25807975
[TBL] [Abstract][Full Text] [Related]
11. A novel rapamycin analog is highly selective for mTORC1 in vivo.
Schreiber KH; Arriola Apelo SI; Yu D; Brinkman JA; Velarde MC; Syed FA; Liao CY; Baar EL; Carbajal KA; Sherman DS; Ortiz D; Brunauer R; Yang SE; Tzannis ST; Kennedy BK; Lamming DW
Nat Commun; 2019 Jul; 10(1):3194. PubMed ID: 31324799
[TBL] [Abstract][Full Text] [Related]
12. Cyclopamine and Rapamycin Synergistically Inhibit mTOR Signalling in Mouse Hepatocytes, Revealing an Interaction of Hedgehog and mTor Signalling in the Liver.
Spormann L; Rennert C; Kolbe E; Ott F; Lossius C; Lehmann R; Gebhardt R; Berg T; Matz-Soja M
Cells; 2020 Jul; 9(8):. PubMed ID: 32751882
[TBL] [Abstract][Full Text] [Related]
13. Caloric restriction effects on liver mTOR signaling are time-of-day dependent.
Tulsian R; Velingkaar N; Kondratov R
Aging (Albany NY); 2018 Jul; 10(7):1640-1648. PubMed ID: 30018180
[TBL] [Abstract][Full Text] [Related]
14. Rapamycin: An InhibiTOR of Aging Emerges From the Soil of Easter Island.
Arriola Apelo SI; Lamming DW
J Gerontol A Biol Sci Med Sci; 2016 Jul; 71(7):841-9. PubMed ID: 27208895
[TBL] [Abstract][Full Text] [Related]
15. Intermittent Administration of Rapamycin Extends the Life Span of Female C57BL/6J Mice.
Arriola Apelo SI; Pumper CP; Baar EL; Cummings NE; Lamming DW
J Gerontol A Biol Sci Med Sci; 2016 Jul; 71(7):876-81. PubMed ID: 27091134
[TBL] [Abstract][Full Text] [Related]
16. Rapamycin Reverses Metabolic Deficits in Lamin A/C-Deficient Mice.
Liao CY; Anderson SS; Chicoine NH; Mayfield JR; Academia EC; Wilson JA; Pongkietisak C; Thompson MA; Lagmay EP; Miller DM; Hsu YM; McCormick MA; O'Leary MN; Kennedy BK
Cell Rep; 2016 Dec; 17(10):2542-2552. PubMed ID: 27926859
[TBL] [Abstract][Full Text] [Related]
17. Rapamycin-mediated mTORC2 inhibition is determined by the relative expression of FK506-binding proteins.
Schreiber KH; Ortiz D; Academia EC; Anies AC; Liao CY; Kennedy BK
Aging Cell; 2015 Apr; 14(2):265-73. PubMed ID: 25652038
[TBL] [Abstract][Full Text] [Related]
18. BMAL1-dependent regulation of the mTOR signaling pathway delays aging.
Khapre RV; Kondratova AA; Patel S; Dubrovsky Y; Wrobel M; Antoch MP; Kondratov RV
Aging (Albany NY); 2014 Jan; 6(1):48-57. PubMed ID: 24481314
[TBL] [Abstract][Full Text] [Related]
19. Chronic rapamycin treatment or lack of S6K1 does not reduce ribosome activity in vivo.
Garelick MG; Mackay VL; Yanagida A; Academia EC; Schreiber KH; Ladiges WC; Kennedy BK
Cell Cycle; 2013 Aug; 12(15):2493-504. PubMed ID: 23839034
[TBL] [Abstract][Full Text] [Related]
20. Rheb1 promotes tumor progression through mTORC1 in MLL-AF9-initiated murine acute myeloid leukemia.
Gao Y; Gao J; Li M; Zheng Y; Wang Y; Zhang H; Wang W; Chu Y; Wang X; Xu M; Cheng T; Ju Z; Yuan W
J Hematol Oncol; 2016 Apr; 9():36. PubMed ID: 27071307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]